c-erbB-2 oncogene as a prognostic marker in breast cancer.
作者信息
Perren T J
出版信息
Br J Cancer. 1991 Mar;63(3):328-32. doi: 10.1038/bjc.1991.78.
Abstract
摘要
相似文献
1
c-erbB-2 oncogene as a prognostic marker in breast cancer.c-erbB-2癌基因作为乳腺癌的预后标志物
Br J Cancer. 1991 Mar;63(3):328-32. doi: 10.1038/bjc.1991.78.
2
Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.c-erbB-2原癌基因的遗传改变作为人类原发性乳腺肿瘤的预后标志物
Oncology. 1993 Nov-Dec;50(6):412-7. doi: 10.1159/000227221.
3
4
Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance.c-erbB2原癌基因在男性乳腺癌中的表达：缺乏预后意义。
Oncology. 1993 Nov-Dec;50(6):408-11. doi: 10.1159/000227220.
5
Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.乳腺癌中c-erbB-2癌蛋白表达的免疫组织化学研究。
Oncology. 1994 Jan-Feb;51(1):47-51. doi: 10.1159/000227309.
6
Quantification of erbB-2/neu levels in tissue.组织中erbB-2/neu水平的定量分析。
Methods Enzymol. 1991;198:290-300. doi: 10.1016/0076-6879(91)98030-a.
7
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.晚期乳腺癌中c-erbB-2蛋白产物表达与内分泌治疗反应的关系。
Br J Cancer. 1992 Jan;65(1):118-21. doi: 10.1038/bjc.1992.22.
8
Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.雌激素受体、c-erbB-2和nm23/NDP激酶在人乳腺癌导管内成分及浸润性成分中的表达
Jpn J Cancer Res. 1992 Aug;83(8):859-65. doi: 10.1111/j.1349-7006.1992.tb01991.x.
9
c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.c-erbB-2癌基因在肝细胞癌和胆管癌中的表达。
J Hepatol. 1992 Mar;14(2-3):377-80. doi: 10.1016/0168-8278(92)90186-s.
10
c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome.
Int J Cancer. 1991 Apr 1;47(6):833-8. doi: 10.1002/ijc.2910470607.
引用本文的文献
1
Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected.驱动致癌作用的磷酸化酪氨酸信号蛋白往往高度相互关联。
Mol Cell Proteomics. 2013 May;12(5):1204-13. doi: 10.1074/mcp.M112.025858. Epub 2013 Jan 28.
2
Significance of Her-2/neu protein over expression in Indian breast cancer patients.Her-2/neu蛋白过表达在印度乳腺癌患者中的意义。
Indian J Surg. 2007 Aug;69(4):122-8. doi: 10.1007/s12262-007-0002-8. Epub 2008 Jul 30.
3
Bimodal gene expression patterns in breast cancer.乳腺癌的双峰基因表达模式。
BMC Genomics. 2010 Feb 10;11 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2164-11-S1-S8.
4
The silent estrogen receptor--can we make it speak?沉默的雌激素受体——我们能否让它“发声”？
Cancer Biol Ther. 2009 Mar 15;8(6):485-96. doi: 10.4161/cbt.8.6.7582.
5
ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.雌激素受体（ER）阴性乳腺癌中ER的重新表达及对内分泌治疗的重新致敏
J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):67-78. doi: 10.1007/s10911-009-9113-0. Epub 2009 Mar 5.
6
Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.继发于骨佩吉特病的骨肉瘤中MYC基因的扩增
Sarcoma. 1997;1(3-4):131-4. doi: 10.1080/13577149778209.
7
Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer.免疫组化检测c-ErbB-2产物定位模式对人类乳腺癌预后的意义
Pathol Oncol Res. 2001;7(3):190-6. doi: 10.1007/BF03032348.
8
Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.乳腺导管原位癌中 Bax 蛋白表达与浸润性导管癌及其他分子标志物的关系。
Pathol Oncol Res. 2000;6(4):256-63. doi: 10.1007/BF03187328.
9
Clinical and Histological Prognostic Factors in Axillary Node-Negative BreastCancer: Univariate and Multivariate Analysis with Relation to 5-Year Recurrence.腋窝淋巴结阴性乳腺癌的临床和组织学预后因素：与5年复发相关的单因素和多因素分析
Breast Cancer. 1995 Apr 30;2(1):51-58. doi: 10.1007/BF02966896.
10
Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis.c-erb-B2扩增在诊断时未接受手术的乳腺癌患者细针穿刺活检中的预后意义
Breast Cancer Res Treat. 1996;39(2):213-20. doi: 10.1007/BF01806188.
本文引用的文献
1
A prognostic index in primary breast cancer.原发性乳腺癌的预后指数
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
2
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.一项比较全乳切除术与保乳手术加或不加放疗治疗乳腺癌的随机临床试验的五年结果。
N Engl J Med. 1985 Mar 14;312(11):665-73. doi: 10.1056/NEJM198503143121101.
3
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌：HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
4
Confirmation of a prognostic index in primary breast cancer.原发性乳腺癌预后指数的验证。
Br J Cancer. 1987 Oct;56(4):489-92. doi: 10.1038/bjc.1987.230.
5
Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases.乳腺癌细胞核DNA含量与临床及形态学因素的预测价值。对227例连续病例的回顾性研究。
Cancer. 1988 Aug 1;62(3):521-30. doi: 10.1002/1097-0142(19880801)62:3<521::aid-cncr2820620314>3.0.co;2-f.
6
Expression of the c-erbB-2 protein in normal and transformed cells.c-erbB-2蛋白在正常细胞和转化细胞中的表达。
Int J Cancer. 1987 Aug 15;40(2):246-54. doi: 10.1002/ijc.2910400221.
7
Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.缺乏c-erbB-2扩增在人类乳腺癌中预后意义的证据。
Oncogene Res. 1988 Sep;3(2):139-46.
8
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.与表皮生长因子受体具有广泛同源性的酪氨酸激酶受体与neu癌基因位于同一染色体位置。
Science. 1985 Dec 6;230(4730):1132-9. doi: 10.1126/science.2999974.
9
Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.通过DNA流式细胞术预测淋巴结阴性乳腺癌患者的复发或生存情况。
N Engl J Med. 1989 Mar 9;320(10):627-33. doi: 10.1056/NEJM198903093201003.
10
Zotero 插件